Target intelligence / Profile preview

Host intestinal ecosystem and immune system

Molecular classification
Other
01

Overview

The host intestinal ecosystem and immune system, often referred to as the gut-immune axis, is a complex symbiotic network consisting of the gut microbiota, the intestinal epithelial barrier, and the mucosal immune system (NIH, 2023). This system plays a fundamental role in maintaining systemic homeostasis, training the immune system to distinguish between commensal organisms and pathogens, and regulating metabolic processes through the production of metabolites like short-chain fatty acids (Nature Reviews Immunology, 2017). Dysbiosis, or the imbalance of this ecosystem, is strongly associated with the pathogenesis of inflammatory bowel disease (IBD), metabolic syndrome, and even neurodegenerative conditions (PubMed, 2021). While not a single molecular target, this system is modulated by various interventions, including probiotics, prebiotics, and fecal microbiota transplantation, to restore health (Cell, 2020). Furthermore, the composition of the intestinal ecosystem has been shown to significantly influence the efficacy of systemic therapies, such as immune checkpoint inhibitors in cancer treatment (Science, 2018).

Other names
Gut-immune axisIntestinal microbiome-immune systemGastrointestinal ecosystemMucosal immune system and microbiota
02

Mechanism of action

Modulation of the intestinal environment through microbial suppression, immune cell recruitment inhibition, or cytokine neutralization to restore mucosal homeostasis and systemic immune balance.

03

Biological functions

Immune responseMetabolic regulationBarrier functionHomeostasisSignal transduction
04

Disease associations

InflammationCancerInfectionAutoimmune diseaseCardiovascular disease
05

Safety considerations

Risk of systemic translocation of bacteriaOpportunistic infections due to immunosuppressionTransfer of antibiotic resistance genesHigh inter-individual variability in therapeutic response
06

Interacting drugs

Infliximab

5 more in the full profile.

07

Biomarkers

Fecal calprotectinMicrobial alpha-diversityShort-chain fatty acid levelsC-reactive protein (CRP)Secretory IgA

Beyond the preview

Go deeper on Host intestinal ecosystem and immune system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host intestinal ecosystem and immune system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call